Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Probiotic Lactobacilli Ameliorate Antibiotic-Induced Cognitive and Behavioral Impairments in Mice
oleh: Dina Yarullina, Vera Novoselova, Anastasia Alexandrova, Alisa Arslanova, Olga Yakovleva, Ilnar Shaidullov, Yury Nikolaev, Galina El-Registan, Vladimir Kudrin, Guzel Sitdikova
Format: | Article |
---|---|
Diterbitkan: | MDPI AG 2024-08-01 |
Deskripsi
Increasing evidence suggests that the gut microbiota, through the “microbiota–gut–brain axis”, can regulate anxiety, mood, and cognitive abilities such as memory and learning processes. Consistently with this, treatments altering the gut microbiota, such as antibiotics and probiotics, may influence brain function and impact behavior. The mechanisms that underlie the interplay between the intestinal microbiota and the brain have been intensively studied. We aimed to investigate the effects of two probiotic lactobacilli strains, <i>Lacticaseibacillus rhamnosus</i> 12L and <i>Lactiplantibacillus plantarum</i> 8PA3, on behavioral disorders in mice induced by a two-week parenteral treatment with broad-spectrum antibiotics. On completion of the treatment, the mice were subjected to behavioral tests, including the open field test (OFT), novel object recognition test (ORT), and T-maze test. Antibiotic-treated mice demonstrated anxiety-related behavior, decreased cognition, and retarded exploratory activity that were ameliorated by the administration of probiotics. As was determined by high-performance liquid chromatography (HPLC), both tested strains produced serotonin and its metabolite 5-hydroxyindoleacetic acid (5-HIAA), as well as dopamine, which was further metabolized into norepinephrine by <i>L. plantarum</i> 8PA3 and epinephrine by <i>L. rhamnosus</i> 12L. Moreover, these lactobacilli were found to harbor catecholamines and 3,4-dihydroxyphenylacetic acid (DOPAC) in their biomass when grown on MRS broth. Additionally, <i>L. plantarum</i> 8PA3 and <i>L. rhamnosus</i> 12L were able to impact oxidative stress via H<sub>2</sub>O<sub>2</sub> production and antioxidant activity, as determined in this study by the ferrous oxidation–xylenol orange (FOX) assay and the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay, respectively. The results obtained in this study support the role of probiotics as a promising therapeutic for neurological disorders. However, more investigations are required to confirm the clinical significance of this finding.